Delivery Systems - Optimizing drug transport
the site of action"
tumor-specific delivery systems for analgetics
(NSAIDs): high local dose for more effective
tumor killing and less toxicity for the
and evaluation of tumor-specific gene therapy
vectors (adeno-, retro- or herpesvirus-based)
delivery systems steer the selective delivery
of drugs to the site of action at the optimal
and evaluation of novel gene and protein
delivery systems such as retroviral expression
immunoliposomes for site directed delivery
of therapeutic agents (e.g. chemokine receptor
antagonists, TFOs, siRNAs as well as DNA
and RNA expressing vectors).